EastWest Bioscience Inc.
EASTH.V
TSX
| Weiss Ratings | EASTH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | EASTH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | EASTH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.00 | |||
| Price History | EASTH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -- | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | -- | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -- | |||
| 52-Week Low % Change | -- | |||
| Price | EASTH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.03 | |||
| 52-Week Low Price | $0.03 | |||
| 52-Week Low Price (Date) | Jul 15, 2024 | |||
| 52-Week High Price (Date) | Jul 15, 2024 | |||
| Valuation | EASTH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | -- | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | 83.33 | |||
| Earnings Per Share (TTM) | 0.00 | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 4.17 | |||
| Price/Book (Q) | 0.94 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | -- | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | EASTH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 100.66M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | EASTH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 800-409-1930 | |||
| Address | 260 Okanagan Avenue East Penticton, BC V2A 3J7 | |||
| Website | www.eastwestbioscience.com | |||
| Country | Canada | |||
| Year Founded | 2016 | |||
| Profitability | EASTH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -315.58% | |||
| Profit Margin | 9.85% | |||
| Management Effectiveness | EASTH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -28.24% | |||
| Return on Equity | -- | |||
| Income Statement | EASTH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 230.90K | |||
| Total Revenue (TTM) | 607.10K | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | 372.60K | |||
| EBITDA (TTM) | -1.83M | |||
| EBIT (TTM) | -1.92M | |||
| Net Income (TTM) | 59.80K | |||
| Net Income Avl. to Common (TTM) | 59.80K | |||
| Total Revenue Growth (Q YOY) | -17.85% | |||
| Earnings Growth (Q YOY) | -267.16% | |||
| EPS Diluted (TTM) | 0.00 | |||
| EPS Diluted Growth (Q YOY) | -238.46% | |||
| Balance Sheet | EASTH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 15.60K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 251.00K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 2.68M | |||
| Current Ratio (Q) | 0.085 | |||
| Book Value Per Share (Q) | $0.03 | |||
| Total Assets (Q) | 5.94M | |||
| Total Current Liabilities (Q) | 2.94M | |||
| Total Debt (Q) | 1.92M | |||
| Total Liabilities (Q) | 3.27M | |||
| Total Common Equity (Q) | 2.68M | |||
| Cash Flow | EASTH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -4.38M | |||
| Cash from Financing (TTM) | 4.65M | |||
| Net Change in Cash (TTM) | -55.40K | |||
| Levered Free Cash Flow (TTM) | -445.40K | |||
| Cash from Operations (TTM) | -325.00K | |||
